It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

coli infection, they may now begin studying the DRD2 receptor and components of its downstream pathway for therapeutic targets. In the study, the researchers used mice infected with Citrobacter ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a ...